Pure Global

Abbott clinical biochemical second-generation total bilirubin test group - Taiwan Registration 43649074541ab9815c5a3707ee4eaa8f

Access comprehensive regulatory information for Abbott clinical biochemical second-generation total bilirubin test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 43649074541ab9815c5a3707ee4eaa8f and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
43649074541ab9815c5a3707ee4eaa8f
Registration Details
Taiwan FDA Registration: 43649074541ab9815c5a3707ee4eaa8f
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Abbott clinical biochemical second-generation total bilirubin test group
TW: ไบžๅŸน่‡จๅบŠ็”ŸๅŒ–็ฌฌไบŒไปฃ็ธฝ่†ฝ็ด…็ด ๆชข้ฉ—่ฉฆๅŠ‘็ต„
Risk Class 2

Registration Details

43649074541ab9815c5a3707ee4eaa8f

DHA05603586606

Company Information

Product Details

This product is used to quantify total bilirubin in human serum or plasma in adults and newborns on the ARCHITECT c System.

A Clinical chemistry and clinical toxicology

A.1110 Bilirubin (total or direct) test system

QMS/QSD;; ่ผธๅ…ฅ

Dates and Status

Oct 19, 2022

Oct 19, 2027